We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
20 July 2020
Versameb AG has closed a CHF 6 million seed financing round. Versameb is engaged in the discovery and development of next-generation RNA-based drugs using its proprietary VERSagile technology platform developing molecules targeting regulation of immune response or regeneration in the fields of dermatology, oncology and myology.
VISCHER AG advises Versameb with Matthias Staehelin, Moritz Jäggy and Dania Salvisberg-Schneider (all Corporate).
Categories: Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Deals & Cases
Attorney at Law and Civil Law Notary (BS/BL)
Attorney at Law
Oculis Holding AG (Nasdaq: OCS) completed a financing of approximately $59 million, consisting of...
Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch...
Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation...